NewsBenzingaEvercore ISI Group mantiene il giudizio Outperform su Medline, alza il target di prezzo a 44 dollari Evercore ISI Group mantiene il giudizio Outperform su Medline, alza il target di prezzo a 44 dollari Benzinga 2026.11.05 14:23 (GMT+0) Open on Benzinga Other news Leerink Partners Initiates Coverage On Erasca with Outperform Rating, Announces Price Target of $35 What's Going on With AST SpaceMobile Stock on Monday? Reported November 16, U.S. CMS Issues Proposed Rule To Target Fraud Across Medicare, Medicaid/CHIP, And The Marketplace; Sees Possible Savings Of $90B Over Next 10 Years 'Highly classified US national security communications network goes down, sources say' -CNN Exclusive Report Maxim Group Downgrades AIB Data Centers to Hold Stock of the Day: Is Pepsi About to Break Out?
Reported November 16, U.S. CMS Issues Proposed Rule To Target Fraud Across Medicare, Medicaid/CHIP, And The Marketplace; Sees Possible Savings Of $90B Over Next 10 Years
'Highly classified US national security communications network goes down, sources say' -CNN Exclusive Report